Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BNT-321 by BioNTech for Solid Tumor: Likelihood of Approval
BNT-321 is under clinical development by BioNTech and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
Data Insights
BNT-321 by BioNTech for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
BNT-321 is under clinical development by BioNTech and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase...